used to examine the issue was not suitable. The discussion included topics that were unrelated to their results. New statistical methods could probably have been used to verify associations or causalities. Also, it would have been appropriate to include patients with confirmed CD who were infected with hepatitis B, regardless of INF-α therapy. In recent years, the use of statistical methods has been demonstrated to be a simple and inexpensive way of developing valuable methodological tools for screening populations and understanding complex diseases. Assessing the value of diagnostic indicators, such as symptoms and lab tests, allows one to estimate the sensitivity and specificity of these indicators and determine the presence or absence of pathology. Statistical methods, such as logistic and nonparametric discriminant analysis, and the selection of features by filters can help in evaluating clinical and lab variables as the foundation of classification-prediction rules. These rules can aid clinicians in estimating the likelihood that an individual will be included in a disease category, avoiding the use of invasive methods and improving quality of life by early diagnosis of these particular pathologies.However, the questions that the authors pose are notable; if there is an actual link between HBV2 and CD, this can launch other studies that determine at-risk groups and develop prevention or therapeutic programs to improve the quality of life of these patients. 
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